questionText: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 January 2024 to Question 8042 on Attention Deficit Hyperactivity Disorder: Drugs, whether it remains her Department's policy to resolve disruptions with the supply of A
answerText: Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working ...
heading: Attention Deficit Hyperactivity Disorder: Drugs